Disclosing Dementia Risk Based on Plasma Phosphorylated Tau

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
BEHAVIORAL

Plasma p-tau risk disclosure

Participants will receive an estimated risk for converting to dementia in the next four years based on age, sex, MMSE score, and plasma p-tau results.

BEHAVIORAL

Standard risk disclosure

Participants will receive an estimated risk for converting to dementia in the next four years based on age, sex, and MMSE score.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER